FIGS' stock price has been in decline since 2021, falling from a peak of $50.40 in that year to a low of $4.30 in 2024. However, over the past year, the steep downward trend has eased, and the stock has stabilized. In the short term, FIGS has established support around $4.50, with technical patterns indicating a potential upside toward $5.05.
While the risk of revisiting the $4.30 low has not been completely eliminated due to long-term downward pressure, the overall downtrend appears to be losing momentum. If this exhaustion continues, the stock could reach a key resistance level of $10 in the coming months. As long as FIGS maintains support at $4.50, the bullish scenario remains likely.
FIGS, Inc. has several strengths, including its stylish and high-quality medical scrubs, which have built strong brand loyalty among healthcare professionals. Its direct-to-consumer model allows for better control over pricing, inventory, and customer engagement. The company also benefits from a high repeat purchase rate, showing strong customer satisfaction. However, FIGS has some drawbacks, such as its higher price point, which may limit affordability for some buyers. Its growth is also constrained by a narrow product focus and limited international presence. Additionally, since it mainly serves healthcare workers, any changes in the industry could impact its sales.
While the risk of revisiting the $4.30 low has not been completely eliminated due to long-term downward pressure, the overall downtrend appears to be losing momentum. If this exhaustion continues, the stock could reach a key resistance level of $10 in the coming months. As long as FIGS maintains support at $4.50, the bullish scenario remains likely.
FIGS, Inc. has several strengths, including its stylish and high-quality medical scrubs, which have built strong brand loyalty among healthcare professionals. Its direct-to-consumer model allows for better control over pricing, inventory, and customer engagement. The company also benefits from a high repeat purchase rate, showing strong customer satisfaction. However, FIGS has some drawbacks, such as its higher price point, which may limit affordability for some buyers. Its growth is also constrained by a narrow product focus and limited international presence. Additionally, since it mainly serves healthcare workers, any changes in the industry could impact its sales.
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.